CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1962.6510.25 (+0.52 %)
PREV CLOSE () 1952.40
OPEN PRICE () 1950.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3846
TODAY'S LOW / HIGH ()1942.10 1974.80
52 WK LOW / HIGH ()1551.05 2636
NSE1963.9011.9 (+0.61 %)
PREV CLOSE() 1952.00
OPEN PRICE () 1952.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1963.90 (261)
VOLUME 37297
TODAY'S LOW / HIGH() 1940.00 1975.90
52 WK LOW / HIGH ()1599 2641
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office :

Address : 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone : 044-24968000 / 8012772888 / 71148000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
09Dec Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ subsidiary -- Caplin Steriles (Caplin) has be..
09Dec Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that it enclosed Press Release on..
08Dec Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ Subsidiary -- Caplin Steriles has received fi..
05Nov Caplin Point Laboratories informs abou
Further to intimation dated 29th October, 2025 Caplin Point Laboratories..
23Oct Caplin Point’s arm gets USFDA’s approv
Caplin Point Laboratories’ Subsidiary -- Caplin Steriles has received fi..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit1025.93394.9
Gross Profit 1290 4416.7
Operating Profit 1350.74665.6
Net Sales 1751.87524.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1128.80 (6.39%)
M.Cap ( in Cr)
777.96
Amrutanjan Healthcar (BSE)
 689.65 (6.38%)
M.Cap ( in Cr)
1993.82
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Shareholding Pattern
PROMOTERS 70.57%
NON-INSTITUTION 20.82%
MUTUAL FUNDS/UTI 1.79%
FI/BANKS/INSURANCE 0.23%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI